Emergence of extended-spectrum beta-lactamases in Pseudomonas aeruginosa: About 24 cases at Rouen University Hospital;Émergence de bêta-lactamases à spectre étendu chez Pseudomonas aeruginosa : à propos de 24 cas au CHU de Rouen

Pathologie Biologie

Volumn 56, Issue 7-8, 2008, Pages 429-434

  David, M ^a   Lemeland, J F ^a,b   Boyer, S ^a,b  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE ROUEN   (France)

Author keywords

Ceftazidime resistance; Extended spectrum lactamases; Pseudomonas aeruginosa; SHV 2a; TEM 116

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE SHV; BETA LACTAMASE SHV 2A; BETA LACTAMASE TEM 116; CEFEPIME; CEFTAZIDIME; CEPHALOSPORINASE; CLOXACILLIN; EXTENDED SPECTRUM BETA LACTAMASE; UNCLASSIFIED DRUG; BACTERIAL DNA; BACTERIAL PROTEIN; BETA LACTAMASE TEM 116, PSEUDOMONAS AERUGINOSA; BETA-LACTAMASE SHV-2A; BETA-LACTAMASE TEM-116, PSEUDOMONAS AERUGINOSA; CEPHALOSPORIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHINA; CLONAL VARIATION; DISK DIFFUSION; ENZYME SYNTHESIS; FRANCE; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; NETHERLANDS; NONHUMAN; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; RANDOM AMPLIFIED POLYMORPHIC DNA; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL; CROSS INFECTION; DRUG EFFECT; ENZYME SPECIFICITY; ENZYMOLOGY; GENETICS; HOSPITAL DEPARTMENT; ISOLATION AND PURIFICATION; MICROBIOLOGY; PSEUDOMONAS INFECTION; STATISTICS;

BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEFTAZIDIME; CEPHALOSPORINS; CROSS INFECTION; DNA, BACTERIAL; FRANCE; HOSPITAL DEPARTMENTS; HOSPITALS, UNIVERSITY; HUMANS; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; RETROSPECTIVE STUDIES; SUBSTRATE SPECIFICITY;

EID: 57049175907     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2008.07.027     Document Type: Article

References (22)

1. Nordmann P. Mechanisms of resistance to betalactam antibiotics in Pseudomonas aeruginosa. Ann Fr Anesth Reanim 22 (2003) 527-530
2. Cavallo J.D., Hocquet D., Plesiat P., Fabre R., and Roussel-Delvallez M. Susceptibility of Pseudomonas aeruginosa to antimicrobials: a 2004 French multicentre hospital study. J Antimicrob Chemother 59 (2007) 1021-1024
3. Weldhagen G.F., Poirel L., and Nordmann P. Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob Agents Chemother 47 (2003) 2385-2392
4. Naas T., and Nordmann P. OXA-type beta-lactamases. Curr Pharm Des 5 (1999) 865-879
5. Walsh T.R., Toleman M.A., Poirel L., and Nordmann P. Metallo-beta-lactamases: the quiet before the storm?. Clin Microbiol Rev 18 2 (2005) 306-325
6. Aubert D., Girlich D., Naas T., Nagarajan S., and Nordmann P. Functional and structural characterization of the genetic environment of an extended-spectrum beta-lactamase blaVEB gene from a Pseudomonas aeruginosa isolate obtained in India. Antimicrob Agents Chemother 48 (2004) 3284-3290
7. Jiang X., Zhang Z., Li M., Zhou D., Ruan F., and Lu Y. Detection of extended-spectrum beta-lactamases in clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 50 (2006) 2990-2995
8. Livermore D.M., and Brown D.F. Detection of beta-lactamase-mediated resistance. J Antimicrob Chemother 48 Suppl. 1 (2001) 59-64
9. Bert F., Branger C., and Lambert-Zechovsky N. Identification of PSE and OXA beta-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. J Antimicrob Chemother 50 (2002) 11-18
10. Cao V., Lambert T., Nhu D.Q., Loan H.K., Hoang N.K., Arlet G., et al. Distribution of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in Vietnam. Antimicrob Agents Chemother 46 (2002) 3739-3743
11. De Champs C., Poirel L., Bonnet R., Sirot D., Chanal C., Sirot J., et al. Prospective survey of beta-lactamases produced by ceftazidime- resistant Pseudomonas aeruginosa isolated in a French hospital in 2000. Antimicrob Agents Chemother 46 (2002) 3031-3034
12. Vignoli R., Varela G., Mota M.I., Cordeiro N.F., Power P., Ingold E., et al. Enteropathogenic Escherichia coli strains carrying genes encoding the PER-2 and TEM-116 extended-spectrum beta-lactamases isolated from children with diarrhea in Uruguay. J Clin Microbiol 43 (2005) 2940-2943
13. Mahenthiralingam E., Campbell M.E., Foster J., Lam J.S., and Speert D.P. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J Clin Microbiol 34 (1996) 1129-1135
14. Jeong S.H., Bae I.K., Lee J.H., Sohn S.G., Kang G.H., Jeon G.J., et al. Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli from a Korean nationwide survey. J Clin Microbiol 42 (2004) 2902-2906
15. Romero E.D., Padilla T.P., Hernandez A.H., Grande R.P., Vazquez M.F., Garcia I.G., et al. Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum beta-lactamases. Diagn Microbiol Infect Dis 59 (2007) 433-437
16. Naiemi N., Duim B., Savelkoul P.H.M., Spanjaard L., de Jonge E., Bart A., et al. Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology. J Clin Microbiol 43 (2005) 4862-4864
17. Naas T., Philippon L., Poirel L., Ronco E., and Nordmann P. An SHV-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa. Antimicrob Agents Chemother 43 (1999) 1281-1284
18. Livermore D.M. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?. Clin Infect Dis 34 (2002) 634-640
19. Philippon A., and Arlet G. Beta-lactamases of Gram negative bacteria: never-ending clockwork!. Ann Biol Clin 64 (2006) 37-51
20. Berthelot P., Grattard F., Mallaval F.O., Ros A., Lucht F., and Pozzetto B. Epidemiology of nosocomial infections due to Pseudomonas aeruginosa, Burkholderia cepacia and Stenotrophomonas maltophilia. Pathol Biol 53 (2005) 341-348
21. Mesaros N., Nordmann P., Plesiat P., Roussel-Delvallez M., Van Eldere J., Glupczynski Y., et al. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin Microbiol Infect 13 (2007) 560-578
22. Morrison Jr. A.J., and Wenzel R.P. Epidemiology of infections due to Pseudomonas aeruginosa. Rev Infect Dis 6 Suppl. 3 (1984) S627-S642